|
"hsu t"的相关文件
显示项目 31-40 / 84 (共9页)
<< < 1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2018-08-14 |
Aminothiazole compounds
|
Jiaang, WT;Hsu, T |
| 國立臺灣海洋大學 |
2018-03 |
A series of organic-inorganic hybrid zinc phosphites containing extra-large channels
|
Wang CM; Pan MF; Lin YJ; Chung MY; Wen YS; Chang Y; Lin HM; Hsu T |
| 國立臺灣海洋大學 |
2017-04 |
Identification of low-molecular-weight vitellogenin 1 (Vg1)-like proteins as nucleotide excision repair (NER) factors in developing zebrafish (Danio rerio) using a transcription-based DNA repair assay.
|
Shen YC; Hsu T; Ling LB; You WC; Liu CW |
| 國家衛生研究院 |
2017-03-21 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2016-08-30 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2016-04-12 |
Pyrazolylamine derivatives reveal the conformational switching between type I and type II binding modes of Anaplastic Lymphoma Kinase (ALK)
|
Tu, CH;Lin, WH;Peng, YH;Hsu, T;Wu, JS;Chang, CY;Lu, CT;Lyu, PC;Shih, C;Jiaang, WT;Wu, SY |
| 國家衛生研究院 |
2015-11-13 |
Pyrrolidine derivatives
|
Jiaang, WT;Chao, YS;Tsai, TY;Hsu, T |
| 國家衛生研究院 |
2015-07 |
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations
|
Chen, CT;Hsu, JTA;Lin, WH;Lu, CT;Yen, SC;Hsu, T;Huang, YL;Song, JS;Chen, CH;Chou, LH;Yen, KJ;Chen, CP;Kuo, PC;Huang, CL;Eugene Liu, H;Chao, YS;Yeh, TK;Jiaang, WT |
| 臺大學術典藏 |
2015 |
Characterization of fungal and bacterial components in gut/fecal microbiome
|
Kirschner R.; Hsu T.; Tuan N.N.; Che C.-L.; Huang S.-L.; ROLAND KIRSCHNER |
| 國立交通大學 |
2014-12-08T15:41:52Z |
Design of a wide-band frequency synthesizer based on TDC and DVC techniques
|
Hsu, T; Hsu, TR; Wang, CC; Liu, YC; Lee, CY |
显示项目 31-40 / 84 (共9页)
<< < 1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
|
